High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

Research output: Contribution to journalArticlepeer-review

9 Scopus citations
Original languageEnglish (US)
Pages (from-to)e576
JournalBlood cancer journal
Volume7
Issue number6
DOIs
StatePublished - Jun 23 2017

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this